These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15190298)

  • 41. Potentially curable neoplasms.
    Sabbath KD; Weitberg AB; Calabresi P
    Dis Mon; 1986 Oct; 32(10):593-652. PubMed ID: 3311668
    [No Abstract]   [Full Text] [Related]  

  • 42. 2003 SNM Highlights Lecture: From proof of principle to proof of value.
    Wagner HN
    J Nucl Med; 2003 Aug; 44(8):11N-36N. PubMed ID: 12934586
    [No Abstract]   [Full Text] [Related]  

  • 43. [Therapeutic intensification and hematopoietic stem cell autotransplantation in the treatment of solid tumors in adults. Principles, realization, and application to the treatment of germinal, trophoblastic, breast, ovarian and small-cell bronchial tumors. 2].
    Lotz JP; Pene F; Bouleuc C; André T; Gisselbrecht C; Bonnak H; Merad Z; Esteso A; Miccio-Bellaiche A; Avenin D
    Rev Med Interne; 1995; 16(2):150-62. PubMed ID: 7709107
    [No Abstract]   [Full Text] [Related]  

  • 44. Trends in nucleoside tracers for PET imaging of cell proliferation.
    Toyohara J; Fujibayashi Y
    Nucl Med Biol; 2003 Oct; 30(7):681-5. PubMed ID: 14499325
    [No Abstract]   [Full Text] [Related]  

  • 45. [Intensive chemotherapy with hematopoietic stem cell autograft in solid malignant tumors in children: current evaluation and prespectives].
    Sommelet D
    Arch Pediatr; 1996 Jul; 3(7):643-8. PubMed ID: 8881173
    [No Abstract]   [Full Text] [Related]  

  • 46. A way forward on the medically appropriate use of white cell growth factors.
    Smith TJ; Hillner BE
    J Clin Oncol; 2012 May; 30(14):1584-7. PubMed ID: 22370327
    [No Abstract]   [Full Text] [Related]  

  • 47. [PET imaging: an update from RSNA 2002].
    Foehrenbach H
    J Radiol; 2003; 84(7-8 Pt 1):761-5. PubMed ID: 13130219
    [No Abstract]   [Full Text] [Related]  

  • 48. British team pioneers PET studies of chemotherapy.
    Reynolds T
    J Natl Cancer Inst; 1995 Feb; 87(4):246-9. PubMed ID: 7707415
    [No Abstract]   [Full Text] [Related]  

  • 49. Being equipped for clinical PET.
    O'Doherty MJ; Marsden PK
    Lancet; 2000 Nov; 356(9243):1701-3. PubMed ID: 11095254
    [No Abstract]   [Full Text] [Related]  

  • 50. The role of imaging in the development of oncologic agents.
    Shields AF; Ho PT; Grierson JR
    J Clin Pharmacol; 1999 Aug; 39(S1):40S-44S. PubMed ID: 10434247
    [No Abstract]   [Full Text] [Related]  

  • 51. Limited Knowledge.
    Bloom SH
    J Clin Oncol; 2021 Dec; 39(35):3993-3995. PubMed ID: 34597126
    [No Abstract]   [Full Text] [Related]  

  • 52. [PET in oncology].
    Lomeña F; Gámez C; Cabrera A; Maldonado A; Jiménez A
    Rev Esp Med Nucl; 2000 Dec; 19(7):510-24, quiz 525-7, 532. PubMed ID: 11171512
    [No Abstract]   [Full Text] [Related]  

  • 53. Relationship between tumor area, tumor volume, and criteria of response in clinical trials.
    Clamon G; Clamon L
    J Clin Oncol; 1993 May; 11(5):1005. PubMed ID: 8487042
    [No Abstract]   [Full Text] [Related]  

  • 54. Optimal lesion number for evaluation of tumor response in response evaluation criteria in solid tumors.
    Rosen MA; Sullivan D
    J Clin Oncol; 2010 Apr; 28(10):e159-60; author reply e161. PubMed ID: 20159810
    [No Abstract]   [Full Text] [Related]  

  • 55. Progression of an untreated pseudotumor.
    Iqbal M; Comp PC; Wu DH
    Haemophilia; 2017 Sep; 23(5):e464-e466. PubMed ID: 28664672
    [No Abstract]   [Full Text] [Related]  

  • 56. Tumour identification using radiopharmaceuticals.
    Britton KE; Granowska M
    Clin Radiol; 1997 Oct; 52(10):731-8. PubMed ID: 9366530
    [No Abstract]   [Full Text] [Related]  

  • 57. Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?
    Çetin G; Çıkrıkçıoğlu MA; Özkan T; Karatoprak C; Ar MC; Eşkazan AE; Ayer M; Cerit A; Gözübenli K; Uysal BB; Erdem S; Ergül N; Tatar G; Çermik TF
    Turk J Haematol; 2015 Sep; 32(3):213-9. PubMed ID: 25912844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PET in lymphoma.
    Collins CD
    Cancer Imaging; 2006 Oct; 6(Spec No A):S63-70. PubMed ID: 17114080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MRI and PET in monitoring response in lymphoma.
    Rahmouni A; Luciani A; Itti E
    Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S106-12. PubMed ID: 16361125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PET scan in the therapeutic strategy.
    Haioun C; Itti E; Rahmouni A; Meignan M; Reyes F
    Hematol J; 2004; 5 Suppl 3():S149-53. PubMed ID: 15190298
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.